-
Caterina Como
New formulations for antitumor drugs oral administration
in adjuvant chemoterapy
Anticancer drugs are commonly administred by intravenously injections because of their narrow therapeutic index. Antitumors are also, in the most of cases,
poor water soluble molecules. To improve their low bioavailability and act a
controlled release it is possible to use drug delivery systems like matrices
and/or nanosystems.
-
Irene Pasquali
Particulate systems drug/hydrophilic polymers obtained
with supercritical carbon dioxide
The use of supercritical carbon dioxide (SC-CO2)
to process various biodegradable/biocompatible polymers for pharmaceutical
and medical applications has generated a great interest in the last two
decades. The advantages in the use of supercritical fluids technology to
produce new drug delivery systems are the high versatility, the flexibility
in offering alternative processing approaches.
-
Marzia Marciello
Innovative systems for mucosal and transmucosal drug administration
The aim of the present research is the development of innovative drug
delivery systems intended for buccal and vaginal administration to obtain a
local or systemic action of the drug loaded. They are based on chitosan or
its derivatives or on other natural polymers (such as hyaluronic acid).
These formulations should allow an easy drug administration, a prolonged
drug contact with the mucosa, an improvement of drug permeation/penetration
through/into mucosa in order to obtain, depending on the therapeutic target,
a more effective local action or systemic absorption of the drug.
-
Simona Motta
Chemical-physical characterization of new nanoparticles carriers for drug delivery
Aim of this work is the analysis and the charactherization of
chemical-physical features of nano and microparticles suitable for drug
delivery and their following transformation into macroscopic agglomerates.
Particular attention will be used for the analysis of physical features (like
internal structure, surface charge, dimensions) that affect encapsulation
capability and release of nanoparticles composed by lechitin and chitosan.
- Chiara Parlati
Respirable microparticle of aminoglicosidic antibiotic for pulmonary administration
Local therapy with inhaled suffering from chronic respiratory infections
with opportunistic bacterial patogens. The objectives of the research is the
innovation in pulmonary delivery of drug for the treatment of local
inflammatory disease. In particular, the aim of this study is to investigate
the pulmonary administration of aminoglicosidic antibiotics as dry powder
inhaler to offer an effective alternative to the nebulization.
 
- Orazio Luca Strusi
Innovation in oral administration of the drugs: assembling of modules for
drug release in controlled release systems for administer combination drugs
The aim of this research is to develop a new system for the
administration of two drugs that are used in combination for malaria therapy.
Thank to Dome Matrix®
technology is possible to made a system compose by different module,
containing different drugs, with different kinetics. In this manner it is
possible optimize the therapy and increase the compliance of the patiences
by reducing the number of tablet units for single administration.
- Benedetta Vietti
Formulation studies for follicular drug delivery
The aim of this work is to develop new formulations for follicular drug
delivery, both for topical application (follicular targeting) and for
sistemic administration (transfollicular delivery).
 
- Ilaria Salvadeo
Preformulation studies of site-specific and prolonged release systems of vancomycin and teicoplanin
The aim of this work is to prepare systems for a site-specific prolonged
release of peptidic antibiotics such as vancomycin and teicoplanin for the
treatment of bone infections like osteomyelitis. To achieve this purpose
salts or physical mixtures with others antibiotics will be used. Other
studies claims possible use of appropriates excipients like hydrophobic
cyclodextrins as controlled release carriers.
 
- Anna Giulia Balducci
Drug delivery systems based on various assemblies of Dome Matrix® modules
 
- Marco Beniamino Pranzo
Cocrystallization for improving biopharmaceutical properties of drugs
The research project aims at the formation of pharmaceutical cocrystals (crystalline
molecular complexes) involving the incorporation of a given API (active
pharmaceutical ingredient) with another pharmaceutically acceptable molecule
(cocrystal former, CCF) in the crystal lattice. The resulting
multi-component crystal will posses a distinct physico-chemical profile,
potentially enabling improvements in properties such as solubility, melting
point or physical stability. In particular, the increase of the solubility
of low solubility API can increase the dissolution rate and therefore
improve the API bioavailability; while the reduction of the solubility of
high solubility API can allow the preparation of controlled release dosage
forms.
 
- Roberto Tozzi
Use of supercritical carbon dioxide for the preparation of drug polymorphs
for the optimization of their technological and biopharmaceutical properties
The work is aimed investigating innovative
technologies based on supercritical CO2
for the production of new solid phases of drugs and to characterise these
new phases from the physico-chemical, technological and biopharmaceutical
points of view. The final purpose of this research is to optimize and to
improve some pharmaceutical products' quality, to guarantee higher efficacy
and safety.
 
- Sara Gibin
Use of cellular culture models for the evaluation of innovative materials
and formulative parameters in the development of therapeutic systems
designed to ophtalmic and mucosal applications
Research project objective is the evaluation and
validation of in vitro models, represented by cellular cultures and
possibly reconstructed tissue 3D, predictive of in vivo behaviour, to be
used in the very early phases of the formulative development. As the main
interest of the project is about the formulative aspects, attention will be
focussed especially on new excipients, and on formulative parameters. Among
the new excipients, in particular new polymeric derivatives will be studied,
for example those obtained by derivatization and combinations/salifications
of already known polymers with molecules able to promote absorption or to
inhibit drug degrading enzymes.